Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | VSV-hIFNbeta-NIS |
Trade Name | |
Synonyms | Voyager-V1|VV1 |
Drug Descriptions |
VSV-hIFNbeta-NIS is oncolytic vesticular stomatitis virus engineered to express human interferon-beta (hIFN-beta) and sodium iodide symporter (NIS), which may inhibit tumor growth (PMID: 26712908, PMID: 22425894). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C131580 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Avelumab + VSV-hIFNbeta-NIS | Avelumab VSV-hIFNbeta-NIS | 0 | 1 |
Cemiplimab + Ipilimumab + VSV-hIFNbeta-NIS | Cemiplimab Ipilimumab VSV-hIFNbeta-NIS | 0 | 1 |
Cemiplimab + VSV-hIFNbeta-NIS | Cemiplimab VSV-hIFNbeta-NIS | 0 | 1 |
Pembrolizumab + VSV-hIFNbeta-NIS | Pembrolizumab VSV-hIFNbeta-NIS | 0 | 1 |
VSV-hIFNbeta-NIS | VSV-hIFNbeta-NIS | 0 | 3 |